TM9SF3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.11799458579753E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.49179998646332E-09 |
Normal-vs-Stage2 |
3.88450000000651E-05 |
Normal-vs-Stage3 |
3.38600003590983E-09 |
Normal-vs-Stage4 |
4.73676653456323E-12 |
Stage1-vs-Stage2 |
7.941600E-01 |
Stage1-vs-Stage3 |
5.276200E-02 |
Stage1-vs-Stage4 |
3.679900E-03 |
Stage2-vs-Stage3 |
3.364800E-01 |
Stage2-vs-Stage4 |
1.971990E-01 |
Stage3-vs-Stage4 |
7.291600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.40383277119827E-12 |
Normal-vs-AfricanAmerican |
8.8587026603193E-11 |
Normal-vs-Asian |
6.252500E-02 |
Caucasian-vs-AfricanAmerican |
1.628630E-01 |
Caucasian-vs-Asian |
5.758800E-01 |
AfricanAmerican-vs-Asian |
1.988830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.63025190306143E-12 |
Normal-vs-Female |
1.10999998081951E-09 |
Male-vs-Female |
4.651000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.76529999999753E-05 |
Normal-vs-Age(41-60Yrs) |
6.48540110503859E-11 |
Normal-vs-Age(61-80Yrs) |
1.68269842504287E-11 |
Normal-vs-Age(81-100Yrs) |
9.03630004156497E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.991800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.766600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.531230E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.282800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.744300E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.158400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.818200E-02 |
Normal-vs-Grade 2 |
2.21840000003137E-06 |
Normal-vs-Grade 3 |
2.76467737592156E-12 |
Normal-vs-Grade 4 |
1.94344540460634E-12 |
Grade 1-vs-Grade 2 |
4.644600E-01 |
Grade 1-vs-Grade 3 |
1.793830E-02 |
Grade 1-vs-Grade 4 |
5.419500E-03 |
Grade 2-vs-Grade 3 |
8.395900E-04 |
Grade 2-vs-Grade 4 |
1.990790E-04 |
Grade 3-vs-Grade 4 |
2.347200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.81030002099902E-09 |
Normal-vs-ccB subtype |
4.62850000548798E-08 |
ccA subtype-vs-ccB subtype |
5.260600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.02160002469054E-09 |
Normal-vs-N1 |
8.214300E-04 |
N0-vs-N1 |
7.438200E-01 |
|
|